Synthesis of sub-10 nm solid lipid nanoparticles for topical and biomarker detection applications
Source abstract
Abstract
Solid lipid nanoparticles (SLNs) are a promising platform for sensing in vivo biomarkers due to their biocompatibility, stability, and their ability to carry a wide range of active ingredients. The skin is a prominent target organ for numerous inflammatory and stress-related biomarkers, making it an excellent site for early detection of physiological imbalance and application of sensory nanoparticles. Though smaller particle size has generally been correlated with increased penetration of skin models, there has been little attention paid to the significance of other nanoparticle synthesis parameters with respect to their physical properties. In this study, we demonstrate the synthesis of sub-10 nm SLNs by the phase inversion temperature (PIT) method. These particles were specifically designed for topical delivery of hydrogen peroxide-detecting chemiluminescent dyes. A systematic design of experiments approach was used to investigate the role of the processing variables on SLN form and properties. The processing variables were correlated with the SLN properties (e.g., dye solubility, phase inversion temperature, particle size, polydispersity, melting point, and latent heat of melting). Statistical analysis revealed that the PIT method, while allowing total control over the thermal properties, resulted in well-controlled synthesis of ultra-small particles, while allowing great flexibility in the processing conditions and incorporated compounds.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advancements in Transdermal Drug Delivery · Essential Oils and Antimicrobial Activity · Dermatology and Skin Diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (30)
Show source-provided references
1. Baroli B (2010) Penetration of nanoparticles and nanomaterials in the skin: fiction or reality? J Pharm Sci 99(1):21–50. doi: 10.1002/jps.2181710.1002/jps.21817 ↗
2. Carbone C, Tomasello B, Ruozi B, Renis M, Puglisi G (2012) Preparation and optimization of PIT solid lipid nanoparticles via statistical factorial design. Eur J Med Chem 49:110–117. doi: 10.1016/j.ejmech.2012.01.00110.1016/j.ejmech.2012.01.001 ↗
3. Chong R, Rho J-ER, Yoon HJ, Rho T-HD, Park PS, Kim Y-H, Lee JH (2012) 1,1′-Oxalyldiimidazole chemiluminescent enzyme immunoassay capable of simultaneously sensing multiple markers. Biosens Bioelectr 32(1):19–23. doi: 10.1016/j.bios.2011.10.05210.1016/j.bios.2011.10.052 ↗
4. Dasari M, Lee D, Erigala VR, Murthy N (2009) Chemiluminescent PEG-PCL micelles for imaging hydrogen peroxide. J Biomed Mater Res, Part A 89(3):561–56610.1002/jbm.a.32430 ↗
5. Figen T, Seyda A, Nevin C (2010) Nanoemulsions as drug delivery systems. In: Colloids in drug delivery. Surfactant science. CRC Press, pp 221–244. doi: 10.1201/9781439818268-c910.1201/9781439818268-c9 ↗
6. Fisher RA (1935) The design of experiments. Oliver & Boyd, Oxford
7. Forgiarini A, Esquena J, González C, Solans C (2000) Studies of the relation between phase behavior and emulsification methods with nanoemulsion formation. In: Buckin V (ed) Trends in colloid and interface science XIV, 115. Progress in Colloid and Polymer Science. Springer Berlin Heidelberg, pp 36–39. doi: 10.1007/3-540-46545-6_810.1007/3-540-46545-6_8 ↗
8. Forgiarini A, Esquena J, González C, Solans C (2001a) Formation and stability of nano-emulsions in mixed nonionic surfactant systems. In: Koutsoukos P (ed) Trends in colloid and interface science XV, 118. Progress in Colloid and Polymer Science. Springer Berlin Heidelberg, pp 184–189. doi: 10.1007/3-540-45725-9_4210.1007/3-540-45725-9_42 ↗
9. Forgiarini A, Esquena J, González C, Solans C (2001b) Formation of nano-emulsions by low-energy emulsification methods at constant temperature. Langmuir 17(7):2076–2083. doi: 10.1021/la001362n10.1021/la001362n ↗
10. Freitas RA (1999) Nanomedicine, I: basic capabilities, 1. Landes Bioscience, Georgetown
11. Korting HC, Schafer-Korting M (2010) Carriers in the topical treatment of skin disease. Handbook of experimental pharmacology (197):435–468. doi: 10.1007/978-3-642-00477-3_1510.1007/978-3-642-00477-3_15 ↗
12. Lee D, Khaja S, Velasquez-Castano JC, Dasari M, Sun C, Petros J, Taylor WR, Murthy N (2007) In vivo imaging of hydrogen peroxide with chemiluminescent nanoparticles. Nat Mater 6(10):765–769. doi: 10.1038/nmat198310.1038/nmat1983 ↗
13. Liu J, Hu W, Chen H, Ni Q, Xu H, Yang X (2007) Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm 328(2):191–195. doi: 10.1016/j.ijpharm.2006.08.00710.1016/j.ijpharm.2006.08.007 ↗
14. Mei Z, Chen H, Weng T, Yang Y, Yang X (2003) Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur J Pharm Biopharm 56(2):189–19610.1016/S0939-6411(03)00067-5 ↗
15. Moser K, Kriwet K, Naik A, Kalia YN, Guy RH (2001) Passive skin penetration enhancement and its quantification in vitro. Eur J Pharm Biopharm 52(2):103–11210.1016/S0939-6411(01)00166-7 ↗
16. Niethammer P, Grabher C, Look AT, Mitchison TJ (2009) A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature 459(7249):996–999. doi: 10.1038/nature0811910.1038/nature08119 ↗
17. Papakostas D, Rancan F, Sterry W, Blume-Peytavi U, Vogt A (2011) Nanoparticles in dermatology. Arch Dermatol Res 303(8):533–550. doi: 10.1007/s00403-011-1163-710.1007/s00403-011-1163-7 ↗
18. Patchan MC-CX, Benkoski J, Theodore M, Le H, Fuller B, Boggs N, Nelson A, Garza L, Sarkar K, Brandacher G, Patrone J (2013) Nanobandage for controlled release of topical therapeutics. TechConnect World Conference, National Harbor, MD, p 255
19. Patrone JB, Patchan M, Calderon-Colon X, Le H, Sample J (2011) Topical sensory nanoparticles for in vivo biomarker detection. NSTI-Nanotech 3:1–4
20. Puglia C, Bonina F (2012) Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals. Expert Opin Drug Deliv 9(4):429–441. doi: 10.1517/17425247.2012.66696710.1517/17425247.2012.666967 ↗
21. Rancan F, Gao Q, Graf C, Troppens S, Hadam S, Hackbarth S, Kembuan C, Blume-Peytavi U, Ruhl E, Lademann J, Vogt A (2012) Skin penetration and cellular uptake of amorphous silica nanoparticles with variable size, surface functionalization, and colloidal stability. ACS Nano 6(8):6829–6842. doi: 10.1021/nn301622h10.1021/nn301622h ↗
22. Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA (2006) Penetration of intact skin by quantum dots with diverse physicochemical properties. Toxicol Sci 91(1):159–165. doi: 10.1093/toxsci/kfj12210.1093/toxsci/kfj122 ↗
23. Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA (2007) Surface coatings determine cytotoxicity and irritation potential of quantum dot nanoparticles in epidermal keratinocytes. J Invest Dermatol 127(1):143–153. doi: 10.1038/sj.jid.570050810.1038/sj.jid.5700508 ↗
24. Schafer-Korting M, Mehnert W, Korting HC (2007) Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev 59(6):427–443. doi: 10.1016/j.addr.2007.04.00610.1016/j.addr.2007.04.006 ↗
25. Sevcikova PVP, Kasparkova V, Krejci J (2011) Formation, characterization and stability of nanoemulsions prepared by phase inversion. Proceeding MACMESE’11 Proceedings of the 13th WSEAS International Conference on Mathematical and Computational Methods in Science and Engineering, pp 132–137
26. Stigbrand M, Ponten E, Irgum K (1994) 1,1′-Oxalyldiimidazole as chemiluminescence reagent in the determination of low hydrogen peroxide concentrations by flow injection analysis. Anal Chem 66(10):1766–1770. doi: 10.1021/ac00082a02710.1021/ac00082a027 ↗
27. Tadros T, Izquierdo P, Esquena J, Solans C (2004) Formation and stability of nano-emulsions. Adv Colloid Interface Sci 108–109:303–318. doi: 10.1016/j.cis.2003.10.02310.1016/j.cis.2003.10.023 ↗
28. Vogt A, Combadiere B, Hadam S, Stieler KM, Lademann J, Schaefer H, Autran B, Sterry W, Blume-Peytavi U (2006) 40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a + cells after transcutaneous application on human skin. J Invest Dermatol 126(6):1316–1322. doi: 10.1038/sj.jid.570022610.1038/sj.jid.5700226 ↗
29. Wertz PW, Downing DT (1989) Free sphingosines in porcine epidermis. Biochimica et biophysica acta 1002 2:213–21710.1016/0005-2760(89)90289-0 ↗
30. Wissing S, Muller R (2002) The influence of the crystallinity of lipid nanoparticles on their occlusive properties. Int J Pharm 242(1–2):377–37910.1016/S0378-5173(02)00220-X ↗